Cronos Group Subject Of SEC Inquiry

This evening, MarketWatch reporter Max Cherney broke the story that Cronos Group (TSX: CRON) (NASDAQ: CRON) has received inquiries from that of the Securities and Exchange Commission related to its revenue recognition practices. The news follows internal investigations conducted by the issuer itself related to certain revenues that were recognized throughout 2019.

As per the report, Cronos staff has been instructed to retain certain documents related to the “confidential and nonpublic inquiry” by the SEC, which is focused on the bulk-resin purchases and biomass wholesale transaction that the company itself is currently reviewing. In a report earlier this week, Cronos revealed that the forensic review of these transactions has resulted in the decrease of 2019 revenues by at least $7.6 million. Associated financial statements filed throughout 2019 will also need to be refiled as a result.

Documents related to the inquiry allegedly require Cronos to keep records that involve a number of public companies that Cronos has transacted and dealt with since June 2018 for various purposes. Those companies include Medipharm Labs (TSX: LABS), Heritage Cannabis (CSE: CANN), TerrAscend Corp (CSE: TER), and 48North Cannabis (TSXV: NRTH).

Cronos Group last traded at $5.87 on the Nasdaq.


Information for this analysis was found via Sedar, MarketWatch and Cronos Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Steadright To Conduct Multi-Phased Exploration At Historic Goundafa Polymetallic Mine

Goliath Resources Drills 10.72 g/t Gold Over 7.83 Metres At Surebet

Related News

Cronos Group, Ginkgo Bioworks Achieve Partnership Productivity Target For CBG Acid

Cronos Group, Inc. (TSX: CRON) and Ginkgo Bioworks announced this morning that its partnership has...

Monday, August 23, 2021, 10:38:00 AM

Did Cronos Group Management Personally Benefit from the Redwood Acquisition?

This morning, Twitter user @xb0y posted findings related to a potentially undisclosed insider transaction related...

Monday, September 9, 2019, 11:10:04 AM

Cronos Group To Close Canadian Facility, Reports Q4 Net Loss Of $133.9 Million

Cronos Group (TSX: CRON) appears to be finally taking steps to address its absolute lack...

Tuesday, March 1, 2022, 08:48:47 AM

Heritage Cannabis Sees Sharples Step Down As CEO, Appointed Chair

Heritage Cannabis (CSE: CANN) has seen a management shakeup occur this morning. The company has...

Wednesday, August 4, 2021, 09:22:38 AM

Heritage Cannabis Sees Assets Sold Off Under CCAA Process

Another cannabis company has seen its assets sold off in connection to creditor protection proceedings....

Friday, August 30, 2024, 09:29:02 AM